HS30・2025

Pharmaceutical products

$310.8BTotal trade
$97.8BExports
$213.1BImports
−$115.3BTrade balance

Medicines, vaccines, and therapeutic preparations. The U.S. is one of the largest pharmaceutical importers, and where this supply chain sits has become a policy concern.

Top subcategories (HS4)

The largest 4-digit subcategories within this chapter by total trade — the more specific goods (e.g., integrated circuits, cars, crude oil).

Subcategory (HS4) Total trade Exports Imports
3002 Human Blood; Animal Blood; Antisera, Vaccines Etc $167.4B $57.3B $110.1B
3004 Medicaments Nesoi, Mixed Or Not, In Dosage Etc Fm $127.6B $34.6B $93.1B
3006 Pharmaceutical Goods In Note 4 To Chapter 30 $7.9B $2.7B $5.2B
3003 Medicaments Nesoi Of Mixtures, Not Dosage Etc Form $3.6B $1.2B $2.4B
3005 Bandages Etc Coated Etc Or In Retail Medic Etc Fm $3.2B $1.4B $1.9B
3001 Glands Etc Dry & Ext; Heparin; Hum Etc Subst Nesoi $1.1B $663,896,696 $460,713,137

Computed: where it sits in U.S. goods trade (2025)

  • Pharmaceutical products accounted for 5.56% of U.S. goods trade (exports plus imports) in 2025, No. 5 of 98 chapters.
  • Imports make up 69% of this category's trade, and imports are about $2.18 for every $1 of exports.
  • The largest partner is Ireland, with 15.4% of the category's trade.
  • The top three partners together account for 34.2% of the category's trade (the higher it is, the more concentrated the partners).
  • The largest single HS4 line makes up 53.8% of this chapter's trade.

Amounts are nominal and cover goods only. Shares are against the total of all 98 chapters in the same year.

Computed: tariff rate profile (US HTS general rates)

  • Of the 60 tariff lines in this chapter, 90% are duty-free. The 58 lines with an ad valorem rate average 0.4%, and 3.3% carry specific or other rates that cannot be shown as a percentage.
  • By rate band: duty-free 90%, up to 5% 5%, 5 to 10% 1.7%, 10 to 20% 0%, over 20% 0%, specific or other 3.3%.
  • The highest ad valorem rate is 6.4% (HTS 3006.93.50).
  • Weighting the headings (HS4) with the largest imports, 6 of them covering 100% of the chapter imports, gives an estimated average rate of 0% (2025 import values).

These are the general (most-favored-nation) rates listed in the HTS (2026HTSRev23), not the duties actually owed. Preferential and FTA rates and the Chapter 99 additional duties (Section 232, 301, IEEPA and others) are excluded. Specific and compound rates are not converted to percentages, and the weighted figure is an estimate using only headings that can be expressed ad valorem. Source: U.S. International Trade Commission (USITC). This site is not a government agency and this is not a basis for customs filings.

Top partner countries

Top partners by total trade (exports plus imports) for this commodity (HS chapter).

Partner Total trade Exports Imports
Ireland $47.8B $5.4B $42.4B
Germany $36.3B $10.2B $26.1B
Switzerland $22.3B $3.2B $19B
Netherlands $19.1B $9.6B $9.5B
Belgium $18.6B $6.7B $11.8B
India $15.8B $771,557,998 $15.1B
China $14.5B $9.1B $5.4B
Japan $14.3B $7.1B $7.2B
France $13.4B $1.9B $11.5B
Italy $13.2B $2.6B $10.6B

Sources (primary)

Figures are based on U.S. Census Bureau international trade statistics (goods trade, full-year totals). This product uses the Census Bureau Data API but is not endorsed or certified by the Census Bureau.

Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.